Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $14,042 | 1,028 | 48.5% |
| Consulting Fee | $12,378 | 5 | 42.7% |
| Travel and Lodging | $1,852 | 8 | 6.4% |
| Education | $393.34 | 12 | 1.4% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $300.00 | 1 | 1.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $11,132 | 122 | $0 (2024) |
| Lilly USA, LLC | $4,703 | 159 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,507 | 57 | $0 (2024) |
| Amgen Inc. | $1,368 | 81 | $0 (2024) |
| Novo Nordisk Inc | $1,296 | 130 | $0 (2024) |
| ABBVIE INC. | $1,289 | 73 | $0 (2024) |
| Biohaven Pharmaceuticals, Inc. | $1,227 | 3 | $0 (2021) |
| Janssen Pharmaceuticals, Inc | $1,127 | 116 | $0 (2024) |
| PFIZER INC. | $837.85 | 72 | $0 (2024) |
| Astellas Pharma US Inc | $548.58 | 17 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,020 | 112 | ABBVIE INC. ($388.23) |
| 2023 | $2,226 | 124 | AbbVie Inc. ($528.16) |
| 2022 | $1,571 | 95 | ABBVIE INC. ($224.85) |
| 2021 | $3,272 | 113 | Biohaven Pharmaceuticals, Inc. ($1,227) |
| 2020 | $1,567 | 70 | AstraZeneca Pharmaceuticals LP ($664.83) |
| 2019 | $4,858 | 175 | Lilly USA, LLC ($3,362) |
| 2018 | $6,665 | 174 | GlaxoSmithKline, LLC. ($5,141) |
| 2017 | $6,787 | 191 | GlaxoSmithKline, LLC. ($5,290) |
All Payment Transactions
1,054 individual payment records from CMS Open Payments — Page 1 of 43
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $15.81 | General |
| Category: Inflammation | ||||||
| 12/13/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $23.84 | General |
| Category: Diabetes Care | ||||||
| 12/12/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $17.31 | General |
| Category: Oncology | ||||||
| 12/11/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $16.56 | General |
| Category: Cardio-renal | ||||||
| 12/02/2024 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $20.55 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 11/26/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $14.83 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/22/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), CAPVAXIVE, GARDASIL 9 | Food and Beverage | In-kind items and services | $17.04 | General |
| Category: VACCINE | ||||||
| 11/20/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $16.41 | General |
| Category: Respiratory | ||||||
| 11/19/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $27.02 | General |
| Category: Cardio-renal | ||||||
| 11/13/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $14.60 | General |
| Category: Gastroenterology | ||||||
| 11/08/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $17.16 | General |
| Category: Diabetes | ||||||
| 10/29/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $13.08 | General |
| Category: Cardio-renal | ||||||
| 10/29/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $8.20 | General |
| Category: NEUROSCIENCE | ||||||
| 10/28/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $18.15 | General |
| Category: Oncology | ||||||
| 10/11/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $21.73 | General |
| Category: Diabetes | ||||||
| 10/09/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $16.99 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/04/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $23.72 | General |
| Category: RESPIRATORY | ||||||
| 09/30/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $15.43 | General |
| Category: Diabetes | ||||||
| 09/27/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $14.24 | General |
| Category: NEUROSCIENCE | ||||||
| 09/26/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $15.35 | General |
| Category: Diabetes | ||||||
| 09/24/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $26.37 | General |
| Category: RESPIRATORY | ||||||
| 09/17/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $6.86 | General |
| Category: NEUROSCIENCE | ||||||
| 09/16/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $17.92 | General |
| Category: Bone Health | ||||||
| 09/12/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $17.35 | General |
| Category: Diabetes | ||||||
| 09/11/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $14.88 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 911 | 4,355 | $208,971 | $114,487 |
| 2022 | 16 | 1,084 | 4,033 | $203,988 | $108,649 |
| 2021 | 15 | 1,154 | 4,014 | $202,886 | $106,438 |
| 2020 | 17 | 1,273 | 3,493 | $191,148 | $81,333 |
All Medicare Procedures & Services
62 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 28 | 2,880 | $63,360 | $48,729 | 76.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 170 | 315 | $50,715 | $24,564 | 48.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 191 | 194 | $46,366 | $22,025 | 47.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 107 | 144 | $15,696 | $8,057 | 51.3% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 43 | 44 | $3,784 | $3,330 | 88.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 146 | 206 | $4,944 | $1,715 | 34.7% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 71 | 150 | $8,100 | $1,420 | 17.5% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 40 | 133 | $4,522 | $1,358 | 30.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 44 | 45 | $1,350 | $1,288 | 95.4% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 13 | 19 | $3,473 | $775.56 | 22.3% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 12 | 14 | $2,156 | $625.89 | 29.0% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 11 | 12 | $1,920 | $395.30 | 20.6% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 14 | 164 | $1,640 | $127.63 | 7.8% |
| 81003 | Automated urinalysis test | Office | 2023 | 21 | 35 | $945.00 | $77.00 | 8.1% |
| J0897 | Injection, denosumab, 1 mg | Office | 2022 | 23 | 2,340 | $51,480 | $38,177 | 74.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 198 | 202 | $48,278 | $22,644 | 46.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 150 | 252 | $40,572 | $21,680 | 53.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 125 | 190 | $20,710 | $10,876 | 52.5% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2022 | 70 | 71 | $6,106 | $4,980 | 81.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 75 | 76 | $2,280 | $2,074 | 90.9% |
| 99495 | Transitional care management services for problem of moderate complexity | Office | 2022 | 13 | 13 | $3,575 | $2,046 | 57.2% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 70 | 143 | $7,722 | $1,370 | 17.7% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2022 | 13 | 24 | $3,949 | $1,071 | 27.1% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 30 | 98 | $3,332 | $1,065 | 32.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 236 | 356 | $8,544 | $1,050 | 12.3% |
About Dr. John Tuttle, MD
Dr. John Tuttle, MD is a Internal Medicine healthcare provider based in Noblesville, Indiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/29/2005. The National Provider Identifier (NPI) number assigned to this provider is 1194712877.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John Tuttle, MD has received a total of $28,966 in payments from pharmaceutical and medical device companies, with $2,020 received in 2024. These payments were reported across 1,054 transactions from 58 companies. The most common payment nature is "Food and Beverage" ($14,042).
As a Medicare-enrolled provider, Tuttle has provided services to 4,422 Medicare beneficiaries, totaling 15,895 services with total Medicare billing of $410,907. Data is available for 4 years (2020–2023), covering 62 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Noblesville, IN
- Active Since 09/29/2005
- Last Updated 04/17/2025
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1194712877
Products in Payments
- NURTEC ODT (Drug) $1,302
- FARXIGA (Drug) $1,007
- XARELTO (Drug) $803.72
- EVENITY (Biological) $709.80
- TRULICITY (Drug) $587.30
- Ozempic (Drug) $572.67
- VRAYLAR (Drug) $547.90
- TRELEGY ELLIPTA (Drug) $448.71
- UBRELVY (Drug) $448.04
- MOUNJARO (Drug) $442.36
- Victoza (Drug) $373.97
- JARDIANCE (Drug) $343.92
- CHANTIX (Drug) $325.09
- SOLIQUA 100/33 (Biological) $315.61
- INVOKANA (Drug) $311.59
- ZENPEP (Drug) $280.34
- QULIPTA (Drug) $273.78
- Kerendia (Drug) $271.17
- ENTRESTO (Drug) $260.33
- Prolia (Biological) $224.49
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Noblesville
Dr. Navneet Lather, Md, Mph, MD, MPH
Internal Medicine — Payments: $105,289
Dr. Ahmad Saltagi, Md, MD
Internal Medicine — Payments: $19,269
Robert Potter, Md, MD
Internal Medicine — Payments: $14,225
Derek Murphy, Md, MD
Internal Medicine — Payments: $10,323
David Tetrick
Internal Medicine — Payments: $6,632
Christian Verhagen, M.d, M.D
Internal Medicine — Payments: $4,449